The BLNK gene helps immune cells called B cells mature and send signals needed to make antibodies, which are proteins that help fight germs. If the BLNK gene does not work properly, the body may make very few B cells and antibodies, which can lead to repeated infections, often starting early in life. This gene plays an important role in how your immune system recognizes and responds to everyday infections. Pathogenic variants in the BLNK gene can cause a rare inherited immune condition called agammaglobulinemia.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others mainly help regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
BLNKGene function
What if the gene works
The BLNK gene helps B cells, a type of white blood cell, pass signals after they detect germs. This supports normal B cell development and helps the immune system make antibodies.
Risk
What if the gene does not work
When the BLNK gene does not work, infection-fighting B cells may not mature, causing very low antibody levels and repeated bacterial infections. Milder to more severe variants can influence how early this appears and how much immune function is affected.
Treatment
What does that mean for your treatment
A pathogenic variant in the BLNK gene is usually managed like other forms of agammaglobulinemia, with regular immunoglobulin replacement as the main treatment. Antibiotics are used promptly for infections, and live vaccines are generally avoided.
Conditions associated with BLNK
Gene function
What if the gene works
Your immune system depends on smooth communication inside B cells, the white blood cells that make antibodies. Instructions in the BLNK gene help build a helper protein that passes along messages after a B cell notices part of a germ. This is a central part of how the BLNK gene helps B cells respond to germs.
Instructions from the BLNK gene help B cells pass signals from their surface receptor to inner control systems. This lets a B cell turn an outside warning into an organized response.
Its protein acts like a meeting point where several signaling partners gather after a B cell receptor is switched on. Bringing these partners together helps messages move in the right order.
The BLNK gene supports normal B cell development as these immune cells mature in the bone marrow. It helps guide the steps that prepare B cells to recognize targets and make antibodies.
Inside B cells, the BLNK gene helps start short calcium signals, which are one way cells transmit instructions. These signals support normal activation and other routine immune cell tasks.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the BLNK gene can change the BLNK protein’s shape, shorten it, or reduce how much is made, which helps explain how BLNK gene variants affect protein function. Because it acts as a signaling scaffold in developing B cells, disruptive variants can weaken key interactions and block downstream signals. More severe variants may leave little or no activity, while milder ones can preserve some signaling. This can influence how early and how strongly related immune features appear.
How variants are linked to conditions
Variants in both copies of the BLNK gene cause agammaglobulinemia, a rare inherited immune condition. This BLNK gene condition usually starts in infancy or childhood with very low antibody levels and frequent bacterial infections, especially in the ears, sinuses, or lungs. Finding two clearly disease-causing BLNK variants in someone with this pattern can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a common, normal feature of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well-characterized variant in one specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For BLNK, risk is mainly shaped by genetics, especially whether a child inherits a disease-causing change from both parents. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change the chance of having a BLNK-related immune condition. Family history can make inherited risk more likely.
Inheritance of BLNK variants
BLNK gene variants linked to disease are inherited in an autosomal recessive pattern. In practical terms, a child usually inherits one altered copy of the BLNK gene from each parent, and the parents are often healthy carriers. When both parents carry a disease-causing BLNK gene variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. This is the main pattern described for BLNK gene inheritance.
What does my BLNK result mean for my family?
For families with a disease-causing change in the BLNK gene, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also have the condition or be carriers, even if they feel well. Other relatives may also carry the same gene change, so the result can matter for family planning and for understanding similar health problems in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the BLNK gene, BLNK genetic testing analyzes DNA from a blood sample, cheek swab, or saliva sample. The lab reads the gene's sequence and compares it with the usual sequence to identify variants.
When should I consider getting a genetic test?
BLNK testing may be worth considering if someone has repeated serious infections, very low antibody levels, or very low levels of infection-fighting blood cells called B cells, especially from infancy or early childhood. It can also help when a rare inherited immune condition runs in the family or doctors are trying to confirm the cause of a strong immune deficiency.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but what they reveal varies with the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get better benefit while the other may have less effect or be more sensitive to side effects. This happens in part because inherited differences can change how the body breaks down, transports, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies gene drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, more personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the BLNK gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response. If you have concerns about side effects, how well a medicine is working, or your general health, talk with your doctor.
History
BLNK came to medical attention in the late 1990s, when researchers studying B cells identified it as a key signaling partner and gave it names including SLP-65 and BASH. Early lab work showed that changes in the BLNK gene could disrupt normal B cell development, which helped explain some forms of inherited low antibody production. Building on this early work, scientists uncovered more about the gene through mouse studies and reports of affected families with agammaglobulinemia, a condition marked by very low levels of infection-fighting antibodies. These findings helped connect cell signaling research with real world immune conditions. Over time, descriptions became more precise, and BLNK became recognized as part of the broader history of genes involved in primary immunodeficiency.